Advisory Committee

The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions.

 

Jennifer R. Cochran, PhD.

Senior Associate Vice Provost for Research,  Stanford University; Founder and Chief Scientific Advisor, Red Tree Capital 

Rajeev Dadoo, PhD

Managing Partner, S.R. One Capital Management 

Michelle Doig

Partner, Omega Funds 

Chris Garabedian

CEO, Xontogeny 

Mark Glickman

CEO, BioFlorida  

Anthony Japour, MD

CEO and President, iTolerance  

Darren Ji, MD, PhD, MBA

Co-Founder, Chairman, CEO, Elpiscience 

Sara Nayeem, MD

Executive Vice President, Investment, Enavate Sciences 

Kimberly Nearing

Venture Partner, BVCF 

Carolyn Ng, PhD

Partner and Managing Director, TPG Life Sciences Innovations 

Jonathan Norris

Managing Director, HSBC Innovation  

Siobhan Pomeroy

Vice President, Corporate Development, Gilead Sciences 

Dennis Purcell

Founder and Senior Advisor, Aisling Capital 

Philip S. Ross

Chairman Global Healthcare, Investment Banking, Jefferies 

Jennifer Sheng

Managing Director,  Healthcare Equity Capital Markets. Citigroup Global Markets 

Aki Tobaru

Partner, Remiges 

Asish Xavier, PhD

Vice President, Venture Investments, Johnson & Johnson Innovation- JJDC 

Alethia Young

CFO, Bicycle Therapeutics